Option chain shows key data for China Pharma Holding's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for China Pharma Holding.

China Pharma Holding (AMEX:CPHI) Stock, Option Chain

China Pharma Holding

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.

Crude Oil and Petroleum Trade in the Crosshairs

Equities

News

Eurozone

Commodities

Markets

Trading Ideas

AIRE

CHSN

CPHI

JNVR

NMAX

Crude Oil Down 2%; Chanson International Shares Spike Higher

Nasdaq index

Intraday Update

AEHL

BJDX

Nasdaq Surges Over 400 Points; China Pharma Shares Plummet

Wall-Street-ai7-1

Earnings

Government

Macro Notification

Market Summary

Guidance

Futures

Treasuries

Economics

Federal Reserve

Pre-Market Outlook

Analyst Ratings

AAPL

AMZN

CECO

LEVI

MSFT

NVDA

PLAY

SHEL

TSLA

U.S. stock futures fell sharply on Monday after 2-days of the crash before closing last week. Futures were over 3% lower in premarket trading.

US Stock Futures Drop Following Massive Tariff-Induced Selloff: Experts Warn Of A Brewing &#39;Great Depression-Like&#39; Pattern

China Pharma Holding Inc

Press Releases

China Pharma Holdings, Inc.  expects to launch its Dry Eye Disease Therapeutic Device in the first quarter of 2025

Offerings

China Pharma Announces the Entry of "At-The-Market" Equity Offering

Contracts

China Pharma Holdings, Inc. Completes Full Redemptions Under Convertible Note Agreement with Streeterville

Stock Split

China Pharma Holdings Inc. Announces 1-for-10 Reverse Stock Split

Anebulo Pharmaceuticals, Inc. - Common Stock

Anebulo Pharmaceuticals

Alto Neuroscience

AN2 Therapeutics

Assertio Holdings

Cognition Therapeutics, Inc. - Common Stock

Cognition Therapeutics

Clearside Biomedical, Inc. - Common Stock

Clearside Biomedical

Cumberland Pharmaceuticals Inc. - Common Stock

Cumberland

Cadrenal Therapeutics, Inc. - Common Stock

Cadrenal Therapeutics

Dare Bioscience

Grace Therapeutics

IGC Pharma

Ikena Oncology

Opus Genetics

Iterum Therapeutics

Lexaria Bioscience

Milestone Pharmaceuticals Inc. - Common Shares

Milestone Pharmaceuticals

NRX Pharmaceuticals

Nutriband

Pulmatrix

Rani Therapeutics Holdings, Inc. - Class A Common Stock

Rani Therapeutics Hldgs

Reviva Pharmaceuticals Holdings, Inc. - Common Stock

Reviva Pharmaceuticals

Scilex Holding

SCYNEXIS

China SXT Pharmaceuticals, Inc. - Common Stock

China SXT Pharmaceuticals

Verrica Pharmaceuticals Inc. - Common Stock

Verrica Pharmaceuticals

Comments

China Pharma Holding

China Pharma Holding (CPHI) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell